Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label placebo in children with FGIDs
NCT02389998Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2014
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in functional abdominal pain (FAP), irritable bowel syndrome (IBS), functional dyspepsia (FD) and 1 more, sponsored by Boston Children's Hospital. Primary endpoint: Mean Daily Pain Intensity at 6 weeks. Started Jul 2014; status: completed.
02
Conditions
functional abdominal pain (FAP)irritable bowel syndrome (IBS)functional dyspepsia (FD)functional gastrointestinal disorder (FGID)
Beyond the preview
Go deeper on NCT02389998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389998.